Nexus Surgical and Medicare Ltd
Incorporated in 1992, Nexus Surgical and Medicare Ltd deals in medical disposable, surgical equipment, pharmaceutical products[1]
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Financial Services Financial Services Finance Other Financial Services
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Dividend Payout % |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Equity Capital |
| Reserves |
| Total Liabilities |
| CWIP |
| Investments |
| Total Assets |
Cash Flows
Figures in Rs. Crores
| Net Cash Flow |
| Free Cash Flow |
| CFO/OP |
Ratios
| Debtor Days |
| Inventory Days |
| Days Payable |
| Cash Conversion Cycle |
| Working Capital Days |
| ROCE % |
Insights
In beta| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Foreign Exchange Expenditure ₹ in '00 ・Standalone data |
|
|||||
| Purchase of Stock-in-Trade ₹ in '00 ・Standalone data |
||||||
| Sale of Products as % of Total Revenue percent ・Standalone data |
||||||
Extracted by Screener AI
Documents
Announcements
- Closure of Trading Window
-
Reappointment Of Independent Non-Executive Woman Director Of The Company For A Second Term Of 5 (Five) Consecutive Years
- AGM approved reappointment of Ms. Neha Kailash Bhageria as Independent Woman Director from 29 Sep 2026 to 28 Sep 2031.
-
Appointment Of Independent Non-Executive Director Of The Company For A Period Of 5 Consecutive Years
- AGM approved appointment of Ashish Durgaprasad Mishra as independent non-executive director from 2 Sep 2026 to 1 Sep 2031.
-
Re-Designation Of Director From Professional Non-Executive Director To Promoter Non-Executive Director
- AGM approved Mr. Ram Swaroop Joshi's re-designation as promoter non-executive director effective 2 Sept 2026.
-
Announcement under Regulation 30 (LODR)-Change in Management
- AGM approved Mr. Anish More as Managing Director for 3 years from 2 Sept 2026; remuneration Rs.24 lakh annually.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
-
Annual Report 2011
from bse
Business Overview:[1]
NSML is in the business of importing and marketing quality surgical and pharma products at economical prices. It holds all the necessary licenses / permissions for Import of above surgical consumables. The company is a wholesale dealer dealing in various sizes of disposal syringe (with and without needle) and pouches of various size used for storage of sterilized equipment and material.